Shuttle Pharmaceuticals Holdings, Inc. Net Income Loss

Quick Answer

Shuttle Pharmaceuticals Holdings, Inc. reported Net Income Loss of -$11.72 million for the year ending 2025.

  • Shuttle Pharmaceuticals Holdings, Inc. showed a decrease of -28.2% in Net Income Loss from 2024 to 2025.
  • This data is from Shuttle Pharmaceuticals Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Shuttle Pharmaceuticals Holdings, Inc.'s Net Income Loss has declined by 917.4%.
  • Historical annual values: Fiscal year 2025: -$11.72 million | Fiscal year 2024: -$9.14 million | Fiscal year 2023: -$6.59 million | Fiscal year 2022: -$3.03 million | Fiscal year 2021: -$1.15 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: